APW
PSTV

Allied Private Wealth’s Plus Therapeutics PSTV Stock Holding History

Allied Private Wealth’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89K Buy
+496
New +$2.71K ﹤0.01% 740

Other funds holding PSTV

ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Allied Private Wealth's PSTV Position: Q2 2026 in Review

Allied Private Wealth opened a new position in Plus Therapeutics (PSTV) in Q2 2026: 496 shares worth $1.89K. The stake represents ﹤0.01% of the portfolio and ranks #740 among its holdings.

4 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.

  • Allied Private Wealth held 496 shares of Plus Therapeutics worth $1.89K as of Q2 2026.
  • Plus Therapeutics was a new Allied Private Wealth position in Q2 2026.
  • Plus Therapeutics made up ﹤0.01% of Allied Private Wealth's portfolio in Q2 2026, its #740 holding.
  • 4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.